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Background: The serum level of amylase (sAm) is commonly used as a biochemical marker for diagnosis and
management of pancreatic disorders. However, the use of the urine level of amylase (uAm) is limited in practice,
because the diagnostic ability of uAm is inferior to that of sAm. In the present study, the possible concordance of
uAm-rerated parameters with sAm was investigated, and evaluate the usefulness of uAm for management of
hyperamylasemia.
Methods: From June 1995 to October 2009, 804 samples of both urine and blood were collected from 128 patients
in order to measure the serum level of amylase (sAm) and the urine level of amylase (uAm) and creatinine (uCr).
Concordance of parameters using uAm compared to sAm was assessed. Parameters used were uAm, amylase
creatinine clearance ratio (ACCR), and the ratio of uAm to uCr (uAm/uCr).
Results: uAm/uCr had the best correlation with sAm (r = 0.779, p < 0.001) compared to uAm (r = 0.620, p < 0.001)
and to ACCR (r = 0.374, p < 0.001), when sAm was over the standard level. The area under the receiver operating
characteristic curve of uAm/uCr (0.884) was significantly higher than that of uAm (0.766) and of ACCR (0.666)
(p < 0.001 for each). The cutoff value of uAm/uCr was 569.8, with a sensitivity of 81.0% and a specificity of 83.1%.
Conclusions: The uAm/uCr ratio correlated with sAm, and may be an alternative to sAm for prediction of
hyperamylasemia. Use of urine samples results in a decreased need for blood sampling, which is especially
beneficial in pediatric patients.
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The serum level of amylase (sAm) is commonly used as
a biochemical marker for diagnosis and management of
pancreatic disorders [1-3]. Amylase is also one of only a
few serum enzymes that are detectable in urine due to
its small size and glomerular filtration [4]. However, the
use of the urine level of amylase (uAm) is limited in
practice [5], because the diagnostic ability of uAm is
inferior to that of sAm [6,7]. In a few reports, uAm has
been used as a marker after endoscopic retrograde cho-
langiopancreatography or pancreas transplantation [8,9].
The amylase creatinine clearance ratio (ACCR) is an
index that uses uAm. ACCR is known to increase during* Correspondence: kta@cc.rim.or.jp
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reproduction in any medium, provided the orpancreatitis; however, it has little diagnostic value be-
cause of its low specificity and sensitivity [5,7].
Since 1990s, we have pursued possibility of using urine
samples for management of pancreatitis, in order to de-
crease occasions of blood sampling. Index using uAm,
however, had little scientific basis. In the present study,
the possible concordance of uAm with sAm was investi-
gated. If a urine sample is equally or more useful and
reliable to measure a biochemical parameter, then pa-
tients can be subject to fewer blood draws in the man-
agement of hyperamylasemia. This is especially relevant
in pediatric patients. For parameters possibly correlated
with sAm, the ratios ACCR and uAm/uCr (the cor-
rected value of uAm divided by the urine level of cre-
atinine (uCr)) were adopted in the present study. The
concept of uAm/uCr is based on other methods that ared. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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urine [10,11].
Methods
Retrospective, observational study was conducted in the
single tertiary referral center, from June 1995 to October
2009. A flow chart of data collection is shown in Figure 1.
Firstly, 2931 urine samples of uAm obtained in our de-
partment were extracted from hospital databases. In these,
1255 samples were obtained with blood sampling measur-
ing sAm on the same day of urine sampling. And in these,
806 samples were also taken with uCr simultaneously.
One case of macroamylasemia (with 2 samples) was ex-
cluded. Diseases in the salivary glands were not included
in the present study. Eventually, total of 804 urine and
blood samples which contained uAm, sAm and uCr were
collected from 128 patients.
Urine samples were collected with the spot collection
technique. The timings of sample collection were vari-
ous and also independent from those of blood sampling.
In neonates and infants, urine was sampled by using dis-
posable Pediatric Urine Collector (Atom®).
Both sAm and uAm were determined by an enzym-
atic method using blocked p-nitrophenyl-α-maltohep-
taoside as a substrate. uCr was determined by an
enzymatic method involving creatinase, sarcosineoxi-
dase and peroxidase. Standard levels of sAm and uAm
in our institution are set at 35–110 IU/L and <450 IU/L,
respectively.
ACCR was calculated in 604 samples (75% of all sam-
ples), because not all blood samples were tested for the
serum level of creatinine (sCr). ACCR was determined
independently of urine volume and time of sampling byFigure 1 A flow chart of data collection.using the formula (uAm / sAm) / (uCr / sCr) [12]; uAm/
uCr was calculated simply by dividing uAm by uCr.
Statistical analyses were performed by using software
(statistical computing; R Foundation for Statistical Com-
puting, Vienna, Austria). Differences between groups
were tested by means of the Student’s t-test or the
Mann–Whitney U test. Associations were assessed by
Pearson’s correlation coefficient test or Spearman’s rank
correlation and expressed as the corresponding correl-
ation coefficient, r. Simple regression analysis was used
to evaluate correlations between sAm and parameters of
urinary amylase: uAm, ACCR, and uAm/uCr. The abil-
ities of the three parameters of urinary amylase to pre-
dict abnormalities of sAm were assessed with receiver
operating characteristic (ROC) analysis. The area under
the curve of each ROC was calculated, and the differ-
ence between each pair was assessed using the critical
ratio. The cutoff value was derived by the point with
shortest distance to the point with a true positive frac-
tion of 100% and a false positive fraction of 0% on the
ROC curve. All results are expressed as mean ± standard
deviation. P values of <0.05 were considered statistically
significant.
Informed consent for participation in the study was
not obtained because all data were collected as part of
routine diagnosis and treatment, and analyzed retro-
spectively. The study protocol was approved by the insti-
tutional ethics committee of Chiba University.
Results
The median age of patients at the sampling was 8.1 years
old (range, 2 months-29 years). The level of amylase
in each age-group is shown in Table 1. Patients were di-
vided into 4 groups: babies (<1 year old, n = 18), infants
(1–5 years old, n = 266), schoolchildren (6–12 years old,
n = 330) and adolescents (>13 years old, n = 190 includ-
ing 22 twenties). Normal sAm was present in 94.4% of
babies, 60.5% of infants, 60.3% of schoolchildren, and
76.3% of adolescents.
Amylase concentrations in different clinical conditions
are shown in Table 2. Choledochal cyst was the diagno-
sis with the largest number of patients in the present
study with 529 samples (65.8% of all samples). In pa-
tients with choledochal cyst, hyperamylasemia can often
be induced by a protein plug stuck in the common chan-
nel [13]. The samples were collected during not only the
perioperative period, but also during outpatient follow-up;
therefore, choledochal cyst samples included a large num-
ber of normal sAm values. Normal sAm accounted for
75.6% of the choledochal cyst and 70.7% of the non-
pancreatic disease samples. Tumors in the present study
included pancreatic tumors (solid pseudopapillary tumors
of the pancreas, n = 2; pancreatoblastoma, n = 1), and
non-pancreatic tumors in the upper abdominal area




(% of normal level)
Urine
amylase
Babies < 1 18 33.5 ± 33.6 (94.4%) 56.6 ± 47.0
Infants 1 – 5 266 178.1 ± 248.9 (60.5%) 600.6 ± 938.7
Schoolchildren 6 – 12 330 183.2 ± 269.5 (60.3%) 755.8 ± 2253.9
Adolescents > 13 190 105.6 ± 91.2 (76.3%) 438.8 ± 616.7
(IU/L)
Figure 2 Association between the serum level of amylase and
the urine level of creatinine, amylase creatinine clearance ratio,
and the level of urinary amylase divided by urine creatinine.
The regression line is drawn in each.
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tumor, n = 1; germ cell tumor, n = 1). Pancreatic duct ob-
struction consisted of pancreatolithiasis (n = 2) and
sphincter of Oddi dysfunction (n = 1). Samples from pa-
tients with “non-pancreatic disease” were those that were
collected for screening of abdominal pain which turned
out to be of non-pancreatic origin. Non-pancreatic disease
includes abdominal pain of unknown origin (n = 14), ul-
cerative colitis (n = 3), gallbladder stone (n = 2), urinary
tract infection (n = 1) and SMA syndrome (n = 1).
Association between sAm and urinary amylase
parameters
Association of sAm with uAm, ACCR, and uAm/uCr are
shown in Figure 2A, 2B, and 2C, respectively. The regres-
sion line is drawn in each figure. The regression lines of
uAm, ACCR and uAm/uCr are represented by the equa-
tions sAm = (0.090 × uAm) + 104.8 (r = 0.610, p < 0.001),
sAm = (22.1 × ACCR) + 116.7 (r = 0.168, p < 0.001), and
sAm = (0.070 × uAm/uCr) + 62.9 (r = 0.859, p < 0.001),
respectively.
With regards to correlation analysis, uAm/uCr had the
best correlation with sAm (r = 0.667, p < 0.001) compared
to uAm (r = 0.508, p < 0.001) and ACCR (r = 0.167, p <
0.001). In 273 samples (34.0% of all samples), sAm was
over the standard level (>110 IU/L). When sAm was over
the standard level, uAm/uCr also had the best correlation
with sAm (r = 0.779, p < 0.001) compared to uAm (r =
0.620, p < 0.001) and ACCR (r = 0.374, p < 0.001). WhenTable 2 The level of amylase in different clinical
conditions
No. Serum amylase
(% of normal level)
Urine
amylase
Choledochal cyst 529 125.0 ± 185.5 (75.6%) 485.8 ± 1547.4
Tumor 87 196.1 ± 216.9 (44.8%) 598.0 ± 1084.5
Trauma 79 370.9 ± 429.7 (39.2%) 1435.8 ± 2195.4
Pancreatic duct
obstruction
47 178.7 ± 177.8 (57.4%) 686.5 ± 1824.4
Pancreatitis 21 138.2 ± 62.4 (19.0%) 725.6 ± 845.5
Non-pancreatic
disease
41 115.7 ± 110.7 (70.7%) 576.1 ± 766.0
(IU/L)sAm was normal, all the three parameters did not cor-
relate well with sAm (uAm, r = 0.245, p < 0.001; ACCR,
r = −0.218, p < 0.001; uAm/uCr, r = 0.289, p < 0.001).
In 11 samples (1.4% of all the samples), sCr was over
the standard level (>1.0 mg/ml). When sCr was over the
standard level, uAm/uCr was 1402.0 ± 2854.1 and corre-
lated with sAm (r = 0.699, p = 0.025). When sCr was
normal, uAm/uCr was 181.0 ± 50.3 and also correlated
with sAm (r = 0.665, p < 10-12).
Correlations between sAm and uAm/uCr were assessed
by different age groups and diseases (Table 3). In infants
and schoolchildren, all the factors had correlations be-
tween sAm and uAm/uCr, while none had correlation in
Table 3 Correlation between sAmy and uA/uC by different age-groups and diseases
Babies Infants School children Adolescents Total
Choledochal cyst 0.331 0.743** 0.636** 0.538** 0.605**
Tumor - 0.829** 0.859** 0.522** 0.715**
Trauma - 0.939** 0.925** na 0.890**
Pancreatic duct obstruction - - 0.923** 0.725** 0.794**
Pancreatitis na - na 0.582** 0.586**
Non-pancreatic disease na 0.713** 0.784** 0.901** 0.827**
Total 0.588* 0.769** 0.764** 0.560** 0.779**
The each value represents the corresponding coefficient of correlation (r).
*:p<0.05, **:p<0.01.
na; not assessed due to small samples (n<10).
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creatic duct obstruction and non-pancreatic disease.
Prediction of sAm abnormalities with urinary amylase
parameters
ROC curves are plotted for abnormal sAm (>110 IU/L)
in Figure 3. The area under the ROC curve of uAm/uCr
(0.884) was significantly higher than that of uAm (0.766)
and ACCR (0.666) (p < 0.001 for each). The cutoff value
of uAm/uCr was 569.8 with a sensitivity of 81.0% and a
specificity of 83.1%.
Discussion
In the diagnosis and management of pancreatic disor-
ders, measurement of sAm has played a central roleFigure 3 Receiver operating characteristic curves for the urine
level of creatinine (uAm, broken line), amylase creatinine
clearance ratio (ACCR, dotted line) and the level of urinary
amylase divided by urine creatinine (uAm/uCr, solid line) as
predictors of abnormal level of serum amylase. The area under
the curve for uAm/uCr is significantly greater than that for uAm
and ACCR.since Elman et al. demonstrated the value of sAm in
diagnosis of pancreatitis [5,14]. However, it is also true
that sAm has problems with respect to diagnostic ability.
Estimates of the sensitivity of amylase range from 60%
to 98% [15,16], although it is difficult to estimate because
elevated sAm itself is frequently used as a diagnostic cri-
terion [5,17,18]. Furthermore, almost 40% of patients
under 3 years of age with a diagnosis of acute pancreatitis
were reported to have normal amylase but elevated lipase
levels [19]. This erratic low sensitivity of sAm has been
explained as resulting from the short half-life of amylase
in the serum [1-3,15]. The specificity of sAm is also not
high enough to use as a screening parameter for pancre-
atic disorders. While hyperamylasemia is often seen in
various pancreatic diseases, extrapancreatic factors also
result in hyperamylasemia (salivary disease, gastrointes-
tinal disease, gynecologic disease, extra-pancreatic tumors,
and others) [1-3]. Hyperamylasemia was found in 9.7% of
patients with appendicitis [20], 9.3% of patients with acute
cholecystitis [21], and 16.0% of patients with a perforated
peptic ulcer [22]. To compensate for the incomplete diag-
nostic ability of sAm, other pancreatic enzymes have been
proposed. In particular, the serum level of lipase is a com-
parable marker of pancreatic disease, but rapid and cost-
effective measurement systems are not broadly available
[1-3]. Urinary trypsinogen-2 strip test has also drawn at-
tention recently for early detection of pancreatitis, but is
not quantitative and less sensitive [23,24]. Therefore, sAm
has some issues concerning its use, but has been used
broadly as practical marker of pancreatic disorders.
Amylase has a relatively small molecular weight of
about 50,000 Daltons; therefore, it passes through the
glomerulus and is one of only a few serum enzymes
detectable in urine [1]. Therefore, uAm can potentially
be used as a marker of hyperamylasemia. The purpose of
the present study was to assess the usefulness of urine
samples in this regard. The leading reason for conducting
this research was that if urine sample is more useful and
reliable, then patients can undergo a urine test as an alter-
native to a blood test. Collection of urine is less invasive
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which can be especially stressful in pediatric patients.
The parameters investigated from urine samples in the
present study were uAm, ACCR and uAm/uCr. First of
all, uAm can be easily obtained from urine samples. By
using a 1-hour value, a superior sensitivity of uAm was
reported in 1963 [25]. However, uAm has recently been
reported to have no further advantages in the diagnosis
of pancreatitis compared to sAm [7,16]. Even if amylase
activity per hour is used as normalization, the diagnostic
performance of uAm is worse than that of sAm [6]. Sec-
ond, ACCR was developed to differentiate pancreatitis
from hyperamylasemia caused by other conditions. The
concept was based on the fact that amylase clearance in-
creases significantly in acute pancreatitis, while creatin-
ine clearance does not [26-28]. However, ACCR also has
problems with specificity and sensitivity, and is consid-
ered to be less important than sAm [7,15,28-30]. Third,
uAm/uCr is the corrected value of uAm divided by uCr.
The concept of uAm/uCr is based on the evidence that
the variabilities of enzyme excretion into the urine are
the smallest when the results are expressed as the ratio
of enzyme activity / uCr [31,32]. Amylase passes through
the renal filtration circuit primarily without passive elim-
ination or reabsorption [33,34]. Therefore, uAm satisfies
the criteria for the use of the correction by uCr [11]. An-
other merit of uAm/uCr is that it can be obtained from
a urine sample, and a blood sample is not required.
In the present study, among the three parameters of
urinary amylase (uAm, ACCR, and uAm/uCr), uAm/uCr
had the best correlation with sAm especially in the pa-
tients with hyperamylasemia, and the best ability to pre-
dict an abnormal elevation of sAm. This result suggests
the potential use of uAm/uCr as an alternative for sAm.
Furthermore, details of the correlation between sAm
and uAm/uCr were evaluated in order to elucidate the
characteristics of uAm/uCr. The correlation between
sAm and uAm/uCr was low in babies, and was signifi-
cant in infants and schoolchildren. This indicates that
the level of amylase itself cannot be used in babies, as
discussed later. The low correlation in adolescents can
be explained by the high rate of normal sAm in adolescent
samples in the present study. In the range of normal sAm,
correlation between sAm and uAm/uCr tended not to be
significant. A number of normal samples were also col-
lected during follow-up for a choledochal cyst, and also
resulted in a low correlation. Low correlation in pancrea-
titis probably results from a low mean sAm (115.7 IU/L)
despite the low rate of normal sAm in this population.
Except for these conditions, correlations were relatively
high in a number of various other conditions, including
tumor, trauma, pancreatic duct obstruction, and non-
pancreatic disease. Also, in renal failure with elevated sCr,
the correlation between sAm and uAm/uCr wassignificant. Therefore, uAm/uCr could be applicable for
various conditions of hyperamylasemia after the first year
of life, and does not appear to be influenced by elevated
sCr. In the management of hyperamylasemia, uAm/uCr
can potentially be used not for diagnosis but as a marker
for following up on levels of amylase.
In the pediatric population, the level of amylase activ-
ity increases with age [1,15]. Amylolytic enzyme activity
was found to be feeble in children under 1 year of age,
and exceeded the average range for adults beyond the
first year [35]. The adult level of pancreatic amylase
activity in duodenal juice is reached at the age of
18 months [36]. In serum, the amylase level reaches the
normal adult level by the age of 8 months [37]; however,
the major component of amylase originates from the
salivary glands. Pancreatic amylase activity in serum
reaches the normal adult level by 7 to 10 years of age
[38,39]. In contrast, the pancreatic proportion of urinary
amylase approaches the adult level by 16 months of age
[40]. These age-dependent specificities should be consid-
ered when interpreting data surrounding sAm and
uAm/uCr in a pediatric population.
A limitation of this study is the characteristics of study
population; because the subjects were patients from our
department of pediatric surgery, the study population
does not match common etiologies of pediatric hypera-
mylasemia in the greater population [19]. In the present
study, the number of the patients with choledochal cyst
was quite high, and only a few cases of pancreatitis from
systemic causes were investigated. Thus, further investi-
gations are needed in different study populations. The
method of urine sampling is also a limitation. The rec-
ommended urine sampling technique is the second
morning urine after voiding the night urine, in order to
avoid the influences of diurnal rhythms of enzyme excre-
tion and collection errors [31]. In the present study,
however, the time of day of urine sampling was not con-
stant, and was also not constant in relation to the time
of blood sampling. These issues of sample collection
caused unavoidable measurement error, but they were
considered acceptable by limiting the time of urine and
blood sampling to the same day and by including a large
number of samples. Furthermore, uAm tends to peak
later and maintain high level longer than sAm [15,41].
These physiological differences also should be consid-
ered in interpreting the data.
Conclusions
uAm/uCr was found to significantly correlate with sAm,
and therefore may be of use as an alternative to sAm
during management of patients with hyperamylasemia.
Use of urine samples results in a decreased number of
blood samples, which is especially important in pediatric
patients. This retrospective preliminary report will need
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the practical usefulness of uAm/uCr in management of
hyperamylasemia.
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